| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |